인바디

041830KOSDAQ의료용 기기 제조업

67.2 / 100

Reference Date: 2026-06-10

Financial Score25.0 / 40

News Sentiment19.2 / 25

Momentum13.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Surged 39.5% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

InBody is a global medical equipment manufacturer established in 1996, specializing in body composition analyzers, automatic blood pressure monitors, and home-use body composition analyzers. With 83% of sales generated overseas, the company achieved a 14.4% revenue increase to 233.9 billion won in 2025.

Number of Employees

370people

Average Salary

52.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

17.07Industry Average 21.515.0Point

In line with industry avg

PBR

1.74Industry Average 1.382.5Point

Higher than industry avg (caution)

ROE

10.10Industry Average 8.004.0Point

In line with industry avg

Debt Ratio

2.62Industry Average 11.658.0Point

Half of industry avg (excellent)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲17.2% (2-year basis)

Operating Profit Growth Rate

0.5 / 3

Avg ▼2.1% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 12.8% (declining, 3yr)

Detailed News Sentiment

9 totalPositive 7Neutral 2Negative 0Average Sentiment Score 76.7

Positive
인바디, 네이버 헬스케어 연동…AI 체성분 관리 협력 [Why 바이오]
인바디는 네이버와의 협력으로 개인 맞춤형 건강 관리 서비스 제공을 확대하여 긍정적인 시장 반응을 기대.
Positive
인바디 헬스케어, 가정용 체성분 측정기 ‘InBody H2’ 와디즈 ...
인바디의 신제품 'InBody H2'가 와디즈를 통해 빠른 펀딩 성공을 거두며 긍정적인 시장 반응을 보임.
Positive
인바디, 비만 관리 시장 확대에…체성분 분석 수요 증가 기대감 [Why...
인바디의 비만 관리 시장 확대에 따른 체성분 분석기 수요 증가로 기업 가치 재평가 기대.

Detailed Momentum

52-week position6.0Point

52w upper range (75%)

Current 41,350Won52-week high 47,35052-week low 23,200

1-month return6.0Point

1m +39.46% (strong rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral주식등의대량보유상황보고서(약식)2026-06-04
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-28
Neutral자기주식처분결과보고서2026-05-28
Neutral주요사항보고서(자기주식처분결정)2026-05-20
Neutral분기보고서 (2026.03)2026-05-14